PRESS RELEASE WASHINGTON &mdash.

We are grateful for Dr. Anderson’s distinguished tenure and many contributions, the Board said. The association offers been very fortunate have Dr. Anderson as CEO for so a long time, and we desire him well. The Panel also announced the Aug. 15, 2015, retirement of Deputy CEO Dr. Michael Honaker. Dr. Honaker helped shepherd the association through its many changes through the years and did much to make APA a great spot to work. Most of the initiatives he set up resulted in APA receiving the 2014Washington PostTop Locations to Work award. He is one of the staff’s most beloved officials.The hazard ratio for a primary end-point event was 0.56 with early ART in comparison with deferred ART .) and 0.65 with IPT as compared with no IPT . There is no significant conversation among the strategies . These findings were robust to adjustment for baseline CD4+ count, the exclusion of patients enrolled before December 2009, the censoring of follow-up data at the time a first CD4+ count of less than 350 cells per cubic millimeter was measured, concern of only events classified as definite, consideration of each end-point component individually, and stratification relating to baseline CD4+ count, as well as in an analysis where individuals with missing data had been categorized as having treatment failing and a per-protocol evaluation .).